Penumbra, Inc. (PEN)
328.69
+0.80
(+0.24%)
USD |
NYSE |
May 22, 16:00
328.71
+0.02
(+0.01%)
Pre-Market: 20:00
Penumbra Free Cash Flow : 212.73M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.475B |
| Abbott Laboratories | 7.378B |
| Insulet Corp. | 387.80M |
| Globus Medical, Inc. | 605.57M |
| Intuitive Surgical, Inc. | 2.834B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 86.97M |
| Cash from Investing (Quarterly) | -30.63M |
| Cash from Financing (Quarterly) | -1.907M |
| Free Cash Flow Per Share (Quarterly) | 1.854 |
| Free Cash Flow to Equity (Quarterly) | 76.82M |
| Free Cash Flow to Firm (Quarterly) | 73.55M |
| Free Cash Flow Yield | 1.64% |